 | • レポートコード：QYR2104Z2560 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、老年医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、用途別市場規模（心血管疾患、関節炎、神経障害、がん、骨粗鬆症、呼吸器）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・老年医療の市場動向 ・企業の競争状況、市場シェア ・老年医療の種類別市場規模（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬） ・老年医療の用途別市場規模（心血管疾患、関節炎、神経障害、がん、骨粗鬆症、呼吸器） ・老年医療の北米市場規模2016-2027（アメリカ、カナダ） ・老年医療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・老年医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・老年医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・老年医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、AstraZeneca、Boehringer Ingelheim、Abbott Laboratories、Sanofi、Bristol-Myers Squibb、Merck、Novartis、Pfizer、GSK） ・結論 |
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.
Market Analysis and Insights: Global Geriatric Medicines Market
The global Geriatric Medicines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geriatric Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geriatric Medicines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geriatric Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geriatric Medicines market.
Global Geriatric Medicines Scope and Market Size
Geriatric Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Geriatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Segment by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotics
1.2.9 Antidepressants
1.3 Market by Application
1.3.1 Global Geriatric Medicines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular diseases
1.3.3 Arthritis
1.3.4 Neurological Disorders
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicines Market Perspective (2016-2027)
2.2 Geriatric Medicines Growth Trends by Regions
2.2.1 Geriatric Medicines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Geriatric Medicines Historic Market Share by Regions (2016-2021)
2.2.3 Geriatric Medicines Forecasted Market Size by Regions (2022-2027)
2.3 Geriatric Medicines Industry Dynamic
2.3.1 Geriatric Medicines Market Trends
2.3.2 Geriatric Medicines Market Drivers
2.3.3 Geriatric Medicines Market Challenges
2.3.4 Geriatric Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicines Players by Revenue
3.1.1 Global Top Geriatric Medicines Players by Revenue (2016-2021)
3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2016-2021)
3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicines Revenue
3.4 Global Geriatric Medicines Market Concentration Ratio
3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2020
3.5 Geriatric Medicines Key Players Head office and Area Served
3.6 Key Players Geriatric Medicines Product Solution and Service
3.7 Date of Enter into Geriatric Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicines Breakdown Data by Type
4.1 Global Geriatric Medicines Historic Market Size by Type (2016-2021)
4.2 Global Geriatric Medicines Forecasted Market Size by Type (2022-2027)
5 Geriatric Medicines Breakdown Data by Application
5.1 Global Geriatric Medicines Historic Market Size by Application (2016-2021)
5.2 Global Geriatric Medicines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Geriatric Medicines Market Size (2016-2027)
6.2 North America Geriatric Medicines Market Size by Type
6.2.1 North America Geriatric Medicines Market Size by Type (2016-2021)
6.2.2 North America Geriatric Medicines Market Size by Type (2022-2027)
6.2.3 North America Geriatric Medicines Market Size by Type (2016-2027)
6.3 North America Geriatric Medicines Market Size by Application
6.3.1 North America Geriatric Medicines Market Size by Application (2016-2021)
6.3.2 North America Geriatric Medicines Market Size by Application (2022-2027)
6.3.3 North America Geriatric Medicines Market Size by Application (2016-2027)
6.4 North America Geriatric Medicines Market Size by Country
6.4.1 North America Geriatric Medicines Market Size by Country (2016-2021)
6.4.2 North America Geriatric Medicines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size (2016-2027)
7.2 Europe Geriatric Medicines Market Size by Type
7.2.1 Europe Geriatric Medicines Market Size by Type (2016-2021)
7.2.2 Europe Geriatric Medicines Market Size by Type (2022-2027)
7.2.3 Europe Geriatric Medicines Market Size by Type (2016-2027)
7.3 Europe Geriatric Medicines Market Size by Application
7.3.1 Europe Geriatric Medicines Market Size by Application (2016-2021)
7.3.2 Europe Geriatric Medicines Market Size by Application (2022-2027)
7.3.3 Europe Geriatric Medicines Market Size by Application (2016-2027)
7.4 Europe Geriatric Medicines Market Size by Country
7.4.1 Europe Geriatric Medicines Market Size by Country (2016-2021)
7.4.2 Europe Geriatric Medicines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicines Market Size (2016-2027)
8.2 Asia-Pacific Geriatric Medicines Market Size by Type
8.2.1 Asia-Pacific Geriatric Medicines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Geriatric Medicines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Geriatric Medicines Market Size by Type (2016-2027)
8.3 Asia-Pacific Geriatric Medicines Market Size by Application
8.3.1 Asia-Pacific Geriatric Medicines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Geriatric Medicines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Geriatric Medicines Market Size by Application (2016-2027)
8.4 Asia-Pacific Geriatric Medicines Market Size by Region
8.4.1 Asia-Pacific Geriatric Medicines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Geriatric Medicines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Geriatric Medicines Market Size (2016-2027)
9.2 Latin America Geriatric Medicines Market Size by Type
9.2.1 Latin America Geriatric Medicines Market Size by Type (2016-2021)
9.2.2 Latin America Geriatric Medicines Market Size by Type (2022-2027)
9.2.3 Latin America Geriatric Medicines Market Size by Type (2016-2027)
9.3 Latin America Geriatric Medicines Market Size by Application
9.3.1 Latin America Geriatric Medicines Market Size by Application (2016-2021)
9.3.2 Latin America Geriatric Medicines Market Size by Application (2022-2027)
9.3.3 Latin America Geriatric Medicines Market Size by Application (2016-2027)
9.4 Latin America Geriatric Medicines Market Size by Country
9.4.1 Latin America Geriatric Medicines Market Size by Country (2016-2021)
9.4.2 Latin America Geriatric Medicines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicines Market Size (2016-2027)
10.2 Middle East & Africa Geriatric Medicines Market Size by Type
10.2.1 Middle East & Africa Geriatric Medicines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Geriatric Medicines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Geriatric Medicines Market Size by Type (2016-2027)
10.3 Middle East & Africa Geriatric Medicines Market Size by Application
10.3.1 Middle East & Africa Geriatric Medicines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Geriatric Medicines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Geriatric Medicines Market Size by Application (2016-2027)
10.4 Middle East & Africa Geriatric Medicines Market Size by Country
10.4.1 Middle East & Africa Geriatric Medicines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Geriatric Medicines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Geriatric Medicines Introduction
11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Geriatric Medicines Introduction
11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Geriatric Medicines Introduction
11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Geriatric Medicines Introduction
11.5.4 Sanofi Revenue in Geriatric Medicines Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Geriatric Medicines Introduction
11.7.4 Merck Revenue in Geriatric Medicines Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Geriatric Medicines Introduction
11.8.4 Novartis Revenue in Geriatric Medicines Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Geriatric Medicines Introduction
11.9.4 Pfizer Revenue in Geriatric Medicines Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Geriatric Medicines Introduction
11.10.4 GSK Revenue in Geriatric Medicines Business (2016-2021)
11.10.5 GSK Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotics
Table 9. Key Players of Antidepressants
Table 10. Global Geriatric Medicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Geriatric Medicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Geriatric Medicines Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Geriatric Medicines Market Share by Regions (2016-2021)
Table 14. Global Geriatric Medicines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Geriatric Medicines Market Share by Regions (2022-2027)
Table 16. Geriatric Medicines Market Trends
Table 17. Geriatric Medicines Market Drivers
Table 18. Geriatric Medicines Market Challenges
Table 19. Geriatric Medicines Market Restraints
Table 20. Global Geriatric Medicines Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Geriatric Medicines Market Share by Players (2016-2021)
Table 22. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2020)
Table 23. Ranking of Global Top Geriatric Medicines Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Geriatric Medicines Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Geriatric Medicines Product Solution and Service
Table 27. Date of Enter into Geriatric Medicines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Geriatric Medicines Revenue Market Share by Type (2016-2021)
Table 31. Global Geriatric Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Geriatric Medicines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Geriatric Medicines Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Geriatric Medicines Revenue Market Share by Application (2016-2021)
Table 35. Global Geriatric Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Geriatric Medicines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Geriatric Medicines Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Geriatric Medicines Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Geriatric Medicines Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Geriatric Medicines Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Geriatric Medicines Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Geriatric Medicines Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Geriatric Medicines Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Geriatric Medicines Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 67. Eli Lilly and Company Company Details
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Geriatric Medicines Product
Table 70. Eli Lilly and Company Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Geriatric Medicines Product
Table 75. AstraZeneca Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Boehringer Ingelheim Company Details
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Geriatric Medicines Product
Table 80. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 81. Boehringer Ingelheim Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Geriatric Medicines Product
Table 85. Abbott Laboratories Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 86. Abbott Laboratories Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Geriatric Medicines Product
Table 90. Sanofi Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Geriatric Medicines Product
Table 95. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Geriatric Medicines Product
Table 100. Merck Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 105. Novartis Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Geriatric Medicines Product
Table 109. Pfizer Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. GSK Company Details
Table 112. GSK Business Overview
Table 113. GSK Geriatric Medicines Product
Table 114. GSK Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million)
Table 115. GSK Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicines Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotics Features
Figure 9. Antidepressants Features
Figure 10. Global Geriatric Medicines Market Share by Application: 2020 VS 2027
Figure 11. Cardiovascular diseases Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Disorders Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicines Report Years Considered
Figure 18. Global Geriatric Medicines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Geriatric Medicines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Geriatric Medicines Market Share by Regions: 2020 VS 2027
Figure 21. Global Geriatric Medicines Market Share by Regions (2022-2027)
Figure 22. Global Geriatric Medicines Market Share by Players in 2020
Figure 23. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2020
Figure 25. Global Geriatric Medicines Revenue Market Share by Type (2016-2021)
Figure 26. Global Geriatric Medicines Revenue Market Share by Type (2022-2027)
Figure 27. North America Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Geriatric Medicines Market Share by Type (2016-2027)
Figure 29. North America Geriatric Medicines Market Share by Application (2016-2027)
Figure 30. North America Geriatric Medicines Market Share by Country (2016-2027)
Figure 31. United States Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Geriatric Medicines Market Share by Type (2016-2027)
Figure 35. Europe Geriatric Medicines Market Share by Application (2016-2027)
Figure 36. Europe Geriatric Medicines Market Share by Country (2016-2027)
Figure 37. Germany Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Geriatric Medicines Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Geriatric Medicines Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Geriatric Medicines Market Share by Region (2016-2027)
Figure 47. China Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Geriatric Medicines Market Share by Type (2016-2027)
Figure 55. Latin America Geriatric Medicines Market Share by Application (2016-2027)
Figure 56. Latin America Geriatric Medicines Market Share by Country (2016-2027)
Figure 57. Mexico Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Geriatric Medicines Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Geriatric Medicines Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Geriatric Medicines Market Share by Country (2016-2027)
Figure 63. Turkey Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 69. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 74. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 75. GSK Revenue Growth Rate in Geriatric Medicines Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed